• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

["摇头丸的早期历史"]

[The early history of "Ecstasy"].

作者信息

Benzenhöfer U, Passie T

机构信息

Senckenbergisches Institut für Geschichte der Medizin, Universität Frankfurt am Main.

出版信息

Nervenarzt. 2006 Jan;77(1):95-6, 98-9. doi: 10.1007/s00115-005-2001-y.

DOI:10.1007/s00115-005-2001-y
PMID:16397805
Abstract

There is no consensus in the literature regarding the early history of MDMA (Methylendioxymethamphetamine, so-called "Ecstasy"). Various authors credit the first synthesis of MDMA to the German chemist Fritz Haber, but it appears neither in his doctoral thesis (Berlin 1891) nor in his accompanying articles. The man who first synthesized MDMA was the chemist Dr. Anton Köllisch, who worked for the German pharmaceutical company Merck. He created MDMA as a by-product while trying to synthesize hydrastinin, a styptic substance. In 1912, Merck filed to patent the applied method of preparation. The patent was issued in 1914, yet no pharmaceutical testing followed at that time.

摘要

关于摇头丸(3,4-亚甲基二氧甲基苯丙胺,即所谓的“摇头丸”)的早期历史,文献中尚无定论。不同的作者认为摇头丸的首次合成归功于德国化学家弗里茨·哈伯,但它既未出现在他1891年于柏林发表的博士论文中,也未出现在他的相关文章里。首次合成摇头丸的人是为德国制药公司默克工作的化学家安东·科利施博士。他在尝试合成一种止血物质——白毛茛碱时,将摇头丸作为副产品创造了出来。1912年,默克公司提交了所应用制备方法的专利申请。该专利于1914年获批,但当时并未进行药物测试。

相似文献

1
[The early history of "Ecstasy"].["摇头丸的早期历史"]
Nervenarzt. 2006 Jan;77(1):95-6, 98-9. doi: 10.1007/s00115-005-2001-y.
2
The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents.摇头丸(迷魂药)的起源再探讨:根据原始文件重构的真实故事。
Addiction. 2006 Sep;101(9):1241-5. doi: 10.1111/j.1360-0443.2006.01511.x.
3
The origin of MDMA ("ecstasy")--separating the facts from the myth.摇头丸(“摇头丸”)的起源——拨开迷雾,认清真相。
Pharmazie. 2006 Nov;61(11):966-72.
4
Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin.重新发现 MDMA(摇头丸):美国化学家亚历山大·舒尔金的作用。
Addiction. 2010 Aug;105(8):1355-61. doi: 10.1111/j.1360-0443.2010.02948.x.
5
The History of MDMA as an Underground Drug in the United States, 1960-1979.1960 - 1979年,摇头丸在美国作为一种地下毒品的历史。
J Psychoactive Drugs. 2016 Apr-Jun;48(2):67-75. doi: 10.1080/02791072.2015.1128580. Epub 2016 Mar 3.
6
An exploration of the history and controversies surrounding MDMA and MDA.对围绕摇头丸和甲烯二氧甲基苯丙胺的历史及争议的探索。
J Psychoactive Drugs. 2001 Jul-Sep;33(3):213-21. doi: 10.1080/02791072.2001.10400568.
7
[A case of acute psychotic episode after a single dose of ecstasy].[一例单次服用摇头丸后出现急性精神病发作的病例]
Encephale. 2001 Mar-Apr;27(2):198-202.
8
A thing patented is a thing divulged: Francis E. Stewart, George S. Davis, and the legitimization of intellectual property rights in pharmaceutical manufacturing, 1879-1911.一项获得专利的事物就是一项被公开的事物:弗朗西斯·E·斯图尔特、乔治·S·戴维斯与制药制造业中知识产权的合法化,1879 - 1911年
J Hist Med Allied Sci. 2009 Apr;64(2):135-72. doi: 10.1093/jhmas/jrn075. Epub 2009 Jan 18.
9
Is there a case for MDMA-assisted psychotherapy in the UK?在英国,MDMA辅助心理治疗有存在的理由吗?
J Psychopharmacol. 2007 Mar;21(2):220-4. doi: 10.1177/0269881107069029.
10
Tabloid.小报
Lancet. 2009 Jan 17;373(9659):205. doi: 10.1016/S0140-6736(09)60060-X.

引用本文的文献

1
3,4-methylenedioxymethamphetamine induces reactive oxygen species-mediated autophagy and thioredoxin-interactive protein/nucleotide-binding domain, leucine-rich containing family, pyrin domain-containing-3 inflammasome activation in dental pulp stem cells.3,4-亚甲基二氧甲基苯丙胺诱导牙髓干细胞中活性氧介导的自噬以及硫氧还蛋白相互作用蛋白/核苷酸结合结构域、富含亮氨酸重复序列家族、含吡啉结构域蛋白3炎性小体激活。
J Dent Sci. 2025 Jul;20(3):1782-1791. doi: 10.1016/j.jds.2025.04.025. Epub 2025 May 6.
2
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.迷幻药商业化:新兴迷幻药产业的全面概述。
Psychedelic Med (New Rochelle). 2023 Sep 13;1(3):150-165. doi: 10.1089/psymed.2023.0013. eCollection 2023 Sep.
3

本文引用的文献

1
Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.摇头丸是3,4-亚甲基二氧甲基苯丙胺(MDMA)吗?含MDMA的摇头丸片剂比例、其剂量水平及对纯度认知变化的综述。
Psychopharmacology (Berl). 2004 May;173(3-4):234-41. doi: 10.1007/s00213-003-1712-7. Epub 2004 Mar 9.
2
An exploration of the history and controversies surrounding MDMA and MDA.对围绕摇头丸和甲烯二氧甲基苯丙胺的历史及争议的探索。
J Psychoactive Drugs. 2001 Jul-Sep;33(3):213-21. doi: 10.1080/02791072.2001.10400568.
3
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology.
MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.基于摇头丸的心理疗法治疗难治性创伤后应激障碍(PTSD):当前证据简要概述
Diseases. 2023 Nov 3;11(4):159. doi: 10.3390/diseases11040159.
4
Can research on entactogens contribute to a deeper understanding of human sexuality?研究致幻剂能否有助于更深入地了解人类性行为?
Pharmacol Rep. 2023 Dec;75(6):1381-1397. doi: 10.1007/s43440-023-00552-7. Epub 2023 Nov 8.
5
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders.在瑞士的临床实践中采用摇头丸和麦角酸二乙酰胺团体治疗模式并强调创伤相关障碍的治疗
Front Psychiatry. 2022 Apr 25;13:863552. doi: 10.3389/fpsyt.2022.863552. eCollection 2022.
6
Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.摇头丸辅助心理治疗创伤后应激障碍的当前观点
J Contemp Psychother. 2018;48(2):99-108. doi: 10.1007/s10879-017-9379-2. Epub 2018 Jan 6.
7
MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.MDMA(3,4-亚甲二氧基甲基苯丙胺)类似物作为描述 MDMA 样效应的工具:一种理解致幻剂药理学的方法。
Curr Neuropharmacol. 2013 Sep;11(5):521-34. doi: 10.2174/1570159X11311050007.
8
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.在患有慢性、治疗抵抗性创伤后应激障碍的受试者中,3,4-亚甲二氧基甲基苯丙胺辅助心理治疗的安全性和有效性:首个随机对照初步研究。
J Psychopharmacol. 2011 Apr;25(4):439-52. doi: 10.1177/0269881110378371. Epub 2010 Jul 19.
9
A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).摇头丸(MDMA)神经行为效应的发育比较。
Neurotoxicol Teratol. 2007 Mar-Apr;29(2):288-300. doi: 10.1016/j.ntt.2006.10.002. Epub 2006 Oct 20.
摇头丸(3,4-亚甲基二氧甲基苯丙胺):历史、神经化学与毒理学
J Am Board Fam Pract. 1999 Mar-Apr;12(2):137-42. doi: 10.3122/jabfm.12.2.137.
4
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].[致幻剂“摇头丸”(3,4-亚甲基二氧甲基苯丙胺)、“伊芙”(3,4-亚甲基二氧乙基苯丙胺)及其他环取代甲基苯丙胺衍生物。非法设计药物中的一类新物质?]
Nervenarzt. 1996 May;67(5):369-80.
5
The background and chemistry of MDMA.摇头丸的背景与化学性质。
J Psychoactive Drugs. 1986 Oct-Dec;18(4):291-304. doi: 10.1080/02791072.1986.10472361.